HRMY Earnings

HRMY reported its earnings on 2026-05-07, showcasing a revenue of 215.39M against an estimate of 222.47M, resulting in a -3.18% surprise. The EPS was 0.55, surpassing the expected 0.76 by -27.63%. The stock experienced a -4.15% price change on the earnings day and a -8.02% change over the next five days, reflecting market reactions to the results.

Following HRMY's earnings announcement on 2026-05-07, the stock price moved by -4.15% on the day of the release. Over the subsequent five days, it saw a -8.02% change. Historically, HRMY's stock price tends to shift by an average of 0.3% in the 10 days leading up to earnings and 0.49% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate HRMY's annual revenue to reach 243.11M, while the EPS is projected at 0.97. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HRMY's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HRMY's stock price typically moves by 0.3% in the 10 days before its earnings and 0.49% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.97 and revenue of 243.11M.

The earnings call summary highlights strong financial performance and optimistic future guidance, particularly with WAKIX's blockbuster revenue projection and robust pipeline advancements. The Q&A session reveals management's strategic focus on expanding CNS indications and protecting IP, despite some uncertainties in litigation and business development. The market cap suggests moderate sensitivity to news, and the overall sentiment is positive, driven by promising product developments and strategic plans. The company's efforts to address analyst concerns and legal challenges indicate a proactive approach, supporting a positive stock price movement prediction.